“…Each domain subgroup considered the following criteria to guide their selection of high‐priority constructs and measures: (1) the strength and source of the current evidence related to weight‐loss outcomes or weight‐related behaviors (e.g., randomized clinical trial versus observational data), (2) the quality of the measure (e.g., validity and reliability), (3) the feasibility of using the measure within a clinical trial (e.g., cost, researcher expertise requirements, logistics), and (4) the participant burden posed by the measure (e.g., administration time, invasiveness). Although the entire working group was presented with this list of criteria for consideration, the four domain subgroups were given a considerable amount of flexibility in how they weighed each criterion and the process by which their domain curated the recommended set of core measures .…”